Supportive Care and Symptom Management for Patients With Immunoglobulin Light Chain (AL) Amyloidosis.
Supportive Care and Symptom Management for Patients With Immunoglobulin Light Chain (AL) Amyloidosis.
复制标题
DOI:
10.3389/fonc.2022.907584
复制
发表时间:
2022
影响因子:
4.7
通讯作者:
Tuchman, Sascha A.
中科院分区:
文献类型:
--
作者:
Jensen, Christopher E.;Byku, Mirnela;Hladik, Gerald A.;Jain, Koyal;Traub, Rebecca E.;Tuchman, Sascha A.
Immunoglobulin light chain (AL) amyloidosis is a disorder of clonal plasma cells characterized by deposition of amyloid fibrils in a variety of tissues, leading to end-organ injury. Renal or cardiac involvement is most common, though any organ outside the central nervous system can develop amyloid deposition, and symptomatic presentations may consequently vary. The variability and subtlety of initial clinical presentations may contribute to delayed diagnoses, and organ involvement is often quite advanced and symptomatic by the time a diagnosis is established. Additionally, while organ function can improve with plasma-cell-directed therapy, such improvement lags behind hematologic response. Consequently, highly effective supportive care, including symptom management, is essential to improve quality of life and to maximize both tolerance of therapy and likelihood of survival. Considering the systemic nature of the disease, close collaboration between clinicians is essential for effective management.
登录
查看更多内容
影响因子:
10.1
作者:
Cowan, Andrew J.;Skinner, Martha;Sanchorawala, Vaishali
通讯作者:
Sanchorawala, Vaishali
影响因子:
1.9
作者:
Anand, Sharath Kumar;Sardari, Hamid;Alimohammadi, Ehsan
通讯作者:
Alimohammadi, Ehsan
影响因子:
9.9
作者:
Byun, Jung-Ick;Moon, Jangsup;Chu, Kon
通讯作者:
Chu, Kon
影响因子:
24
作者:
El-Am, Edward A.;Dispenzieri, Angela;Nkomo, Vuyisile T.
通讯作者:
Nkomo, Vuyisile T.
影响因子:
12.8
作者:
D'Souza A;Brazauskas R;Dispenzieri A;Panepinto J;Flynn KE
通讯作者:
Flynn KE